Correlation Between BriaCell Therapeutics and NRx Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both BriaCell Therapeutics and NRx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BriaCell Therapeutics and NRx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BriaCell Therapeutics Corp and NRx Pharmaceuticals, you can compare the effects of market volatilities on BriaCell Therapeutics and NRx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BriaCell Therapeutics with a short position of NRx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of BriaCell Therapeutics and NRx Pharmaceuticals.
Diversification Opportunities for BriaCell Therapeutics and NRx Pharmaceuticals
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between BriaCell and NRx is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding BriaCell Therapeutics Corp and NRx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NRx Pharmaceuticals and BriaCell Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BriaCell Therapeutics Corp are associated (or correlated) with NRx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NRx Pharmaceuticals has no effect on the direction of BriaCell Therapeutics i.e., BriaCell Therapeutics and NRx Pharmaceuticals go up and down completely randomly.
Pair Corralation between BriaCell Therapeutics and NRx Pharmaceuticals
Assuming the 90 days horizon BriaCell Therapeutics is expected to generate 11.97 times less return on investment than NRx Pharmaceuticals. But when comparing it to its historical volatility, BriaCell Therapeutics Corp is 12.62 times less risky than NRx Pharmaceuticals. It trades about 0.13 of its potential returns per unit of risk. NRx Pharmaceuticals is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 8.00 in NRx Pharmaceuticals on August 31, 2024 and sell it today you would lose (2.90) from holding NRx Pharmaceuticals or give up 36.25% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 85.48% |
Values | Daily Returns |
BriaCell Therapeutics Corp vs. NRx Pharmaceuticals
Performance |
Timeline |
BriaCell Therapeutics |
NRx Pharmaceuticals |
BriaCell Therapeutics and NRx Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with BriaCell Therapeutics and NRx Pharmaceuticals
The main advantage of trading using opposite BriaCell Therapeutics and NRx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BriaCell Therapeutics position performs unexpectedly, NRx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NRx Pharmaceuticals will offset losses from the drop in NRx Pharmaceuticals' long position.BriaCell Therapeutics vs. Cue Biopharma | BriaCell Therapeutics vs. Eliem Therapeutics | BriaCell Therapeutics vs. Inhibrx | BriaCell Therapeutics vs. Molecular Partners AG |
NRx Pharmaceuticals vs. Cue Biopharma | NRx Pharmaceuticals vs. Eliem Therapeutics | NRx Pharmaceuticals vs. Inhibrx | NRx Pharmaceuticals vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |